Naba Alsaha H1 2026 profit climbs 7% to SAR 15.2M

Naba Alsaha Medical Services Co. reported a net profit rise to SAR 15.2 million in H1 2026, compared to SAR 14.2 million a year earlier.

Current Half Annual Comparison (Million Riyal)

Compared With The

Item	H1 2025	H1 2026	Change‬
Revenues	98.09	102.43	4.4 %
Gross Income	32.14	34.05	6.0 %
Operating Income	14.18	15.22	7.3 %
Net Income	14.21	15.23	7.2 %
Average Shares	21.00	21.00	-
Earnings Per Share before unusual items (Riyal)	0.68	0.73	7.2 %
EPS (Riyal)	0.68	0.73	7.2 %

Item	H2 2025	H1 2026	Change‬
Revenues	103.72	102.43	(1.2 %)
Gross Income	34.05	34.05	0.0 %
Operating Income	16.62	15.22	(8.4 %)
Net Income	13.32	15.23	14.3 %
Average Shares	21.00	21.00	-
Earnings Per Share before unusual items (Riyal)	0.63	0.73	14.3 %
EPS (Riyal)	0.63	0.73	14.3 %

The higher profit was mainly attributed to a 4.4% year-on-year (YoY) rise in revenues to approximately SAR 4.3 million, driven by an increase in the patient numbers across outpatient clinics, inpatient departments, and ancillary medical services.

Other contributing factors included improved operational efficiency and the favorable ratio of revenue growth to expenses, which contributed to higher profit margins and net profit.

On a sequential basis, net earnings rose 14.3% from SAR 13.3 million in H2 2025.

Shareholders’ equity, no minority interest, reached SAR 238.1 million by the end of the current period, compared to SAR 210.7 million in the prior-year period.

View More Financial Results

Naba Alsaha H1 2026 profit climbs 7% to SAR 15.2M

Content Summary:

Comments Analysis:

Current Half Annual Comparison (Million Riyal)

View other reports